Herpes Zoster: all 370 studies
Page 3 of 4. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of AgeTerminatedNCT05701800Phase 1
- Biomarker Study in Patients With Herpes ZosterCompletedNCT05685797Not applicable
- A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella VaccineActive, not recruitingNCT05669625Phase 3
- An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 YearsStatus unknownNCT05664152Not applicable
- A Clinical Trial of PEGIFNα1b in Chinese Healthy AdultsCompletedNCT05639803Phase 1
- Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and AboveCompletedNCT05636436Phase 1
- Herpes Virus Infections in Kidney Transplant PatientsActive, not recruitingNCT05604911
- Vitamin C as add-on Therapy in Patients With Acute Herpes ZosterTerminatedNCT05561257Phase 2
- A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A VaccineCompletedNCT05526820Phase 4
- A Study Exploring Efficacy of Peginterferon in Patients With Herpes ZosterCompletedNCT05492591Phase 2
- NPC-06 to Pain Associated With Acute Herpes ZosterCompletedNCT05480553Phase 3
- Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui ProvinceStatus unknownNCT05470855Phase 4
- Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster VirusStatus unknownNCT05460429Phase 4
- A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older AdultsActive, not recruitingNCT05371080Phase 3
- The Efficacy and Safety of Intradermal Acupuncture for Acute Herpes ZosterStatus unknownNCT05348382Not applicable
- Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and OlderActive, not recruitingNCT05304351Phase 2
- Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult VolunteersCompletedNCT05245838Phase 1
- HIV Indicator Diseases in Hospital and Primary CareStatus unknownNCT05225493
- Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years OldCompletedNCT05158777Phase 3
- An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster ImmunizationCompletedNCT05150392Phase 3
- Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)CompletedNCT05082688Phase 2
- Prospective Observation of the Fluoroscopy-guided Cervical Epidural Approach Using the Contralateral Oblique ViewCompletedNCT04774458Not applicable
- Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCTWithdrawnNCT04748939Phase 4
- Erector Spinae Block Versus Thoracic Paravertebral Block for Acute Thoracic Herpes ZosterStatus unknownNCT04656821Phase 4
- Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home ResidentsCompletedNCT04523246Early Phase 1
- Recombinant Zoster Vaccine in Stable SLE PatientsStatus unknownNCT04516408Not applicable
- Study on Efficacy of Attenuated Zoster Vaccine, LiveCompletedNCT04334577Phase 3
- Occlusion vs Standard Treatment for the Treatment of Herpes ZosterStatus unknownNCT04258930Not applicable
- The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataCompletedNCT04239521
- Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult VolunteersCompletedNCT04210752Phase 1
- Stellate Ganglion Block in Herpes ZosterCompletedNCT04188327Not applicable
- NPC-06 to Acute Pain in Herpes ZosterTerminatedNCT04139330Phase 2
- Regional Anesthesia to Relief Zoster PainWithdrawnNCT04133142Not applicable
- Treatment of Chronic Postherpetic Pain With Autologous Fat Grafting - A RCTCompletedNCT04099706Not applicable
- Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) PatientsCompletedNCT04089930
- Pharmacokinetics of Valacyclovir Oral Solution in ChildrenTerminatedNCT04081480Not applicable
- A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 YearsCompletedNCT04072497Phase 1/2
- Herpes Zoster: Risk Factors, Complications and Special SituationsCompletedNCT03903237
- Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER)CompletedNCT03886038Phase 4
- Frequency of Putative Enteric Zoster Diagnosed Using Saliva Samples in Patients With Abdominal Pain: a Prospective StudyCompletedNCT03862092Not applicable
- Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult SubjectsCompletedNCT03820414Phase 1
- Efficacy of Pregabalin for the Treatment of Acute Herpetic NeuralgiaCompletedNCT03809702Phase 4
- The Superiority of Contralateral Oblique View for Mid-thoracic Epidural AssessCompletedNCT03789955Not applicable
- Recombinant Subunit Herpes Zoster Vaccine in VZV-Seronegative Organ Transplant RecipientsCompletedNCT03685682Phase 3
- The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using AbataceptCompletedNCT03604406Phase 2
- Treatment of Chronic Postherpetic Pain With Fat GraftingCompletedNCT03584061Not applicable
- A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella VaccineCompletedNCT03555071Phase 3
- Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes ZosterCompletedNCT03553472
- Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster VirusStatus unknownNCT03509701
- Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung TransplantationStatus unknownNCT03493776Phase 4
- Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A VaccineStatus unknownNCT03330171Phase 4
- Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of AgeCompletedNCT03314103Phase 3
- Optimal Timing of Zoster Vaccine After Hematopoietic Stem Cell TransplantationCompletedNCT03192319Not applicable
- Tzanck Smear With Methylene Blue Stain for HerpesStatus unknownNCT03178747Phase 3
- Safety Study of NBP608 in Healthy Adult VolunteersCompletedNCT03121638Phase 1
- Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic NeuralgiaStatus unknownNCT03120962Not applicable
- Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and OverCompletedNCT03120364Phase 3
- Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and OverCompletedNCT03116594Phase 2/3
- The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of AgeCompletedNCT03114982Phase 2
- Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of AgeCompletedNCT03114943Phase 3
- Regional-anaesthesiological Infiltration Techniques for the Management of Chronic Pain: a Retrospective StudyCompletedNCT03066037
- Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic PatientsStatus unknownNCT03016884Phase 4
- A Blind, Randomized and Controlled Study of Live Attenuated Varicella VaccinesCompletedNCT02981836Phase 3
- A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and ChildrenCompletedNCT02965404Phase 1
- Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoCompletedNCT02902822Not applicable
- Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of FoodCompletedNCT02852876Phase 1
- Herpes Zoster Prevalence in Frailty ConsultationsCompletedNCT02832986
- A Retrospective Chart Review Study of Gene-Eden-VIR/NovirinCompletedNCT02715752
- Optimal Timing of Zoster Vaccine After Zoster IllnessCompletedNCT02704572Not applicable
- Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine.WithdrawnNCT02692066
- Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature NewbornsStatus unknownNCT02689700
- Study to Evaluate the Safety and Pharmacokinetics of Topically Applied 40% Lidocaine Gel Compared With Placebo in Subjects With Acute Herpes Zoster (Shingles) PainTerminatedNCT02679339Phase 1
- Reactivation of Varicella Zoster Virus and Risk of Vascular DiseaseWithdrawnNCT02559596
- Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and OlderCompletedNCT02526745Phase 1/2
- Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus VaccineStatus unknownNCT02514018Phase 4
- Review of Human Herpes Viruses in BurnsCompletedNCT02452229
- Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated PainCompletedNCT02452112Phase 2/3
- A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic NeuralgiaTerminatedNCT02412917Phase 3
- Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic TherapyTerminatedNCT02408159Phase 4
- VZV Vaccine for Hematopoietic Stem Cell TransplantationCompletedNCT02329457Phase 2/3
- A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy VolunteersCompletedNCT02322957Phase 1
- A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)WithdrawnNCT02180295Phase 3
- Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella VaccineCompletedNCT02173899Phase 4
- A Study of Vacyless® Versus Valtrex® in Patients With Herpes ZosterCompletedNCT02152800Phase 4
- Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes ZosterCompletedNCT02151240Phase 4
- Study on Effectiveness of 2-dose Live Attenuated Varicella VaccineStatus unknownNCT02146469Phase 4
- Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year OldsCompletedNCT02114333Phase 1
- Persistence of Varicella Immunity in Hospital Employees Receiving Varicella VaccineWithdrawnNCT02026089Phase 4
- Varicella-related Hospitalizations in TurkeyCompletedNCT01887496
- A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and AboveCompletedNCT01873365
- The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses VaccinationStatus unknownNCT01866566Phase 4
- The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose VaccinationStatus unknownNCT01830283Phase 4
- Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the PhilippinesWithdrawnNCT01738841
- Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of ValacyclovirCompletedNCT01689285Phase 1
- Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without GelatinCompletedNCT01684072Phase 4
- Palatability Testing of a New Paediatric Formulation of ValacyclovirCompletedNCT01682109Phase 4
- A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)WithdrawnNCT01626794Phase 3
- Distances From Cricoid Cartilage to the Targets of Stellate Ganglion BlockStatus unknownNCT01601925Not applicable
- ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)CompletedNCT01600079
- Herpes Zoster Vaccine for Bone Marrow Transplant DonorsCompletedNCT01573182Phase 2